• 不 限
  • 期刊论文
  • 硕博论文
  • 会议论文
  • 报 纸
  • 英文论文
  2. 您的位置
  3. 首页
  4. 会议论文
  5. Pericyte coverage of intratumoral vasculature is a predictor for bevacizumab efficacy in metastatic

Pericyte coverage of intratumoral vasculature is a predictor for bevacizumab efficacy in metastatic

来源 :第五届广州国际肿瘤学会议暨第一届中国抗癌协会肿瘤靶向治疗专业委员会年会 | 被引量 : 0次 | 上传用户：xjj
【摘 要】
：
Background: Tumor vessels supported by pericytes were considered to be responsible for the failure of some anti-angiogenic agents.It remains undefined when it comes to bevacizumab.We tried to analysis
【作 者】
：
Chang Jiang Yu-Hua Huang Jia-Bin Lu Yuan-Zhong Yang Hui-Lan Rao Bei Zhang Wen-Zhuo He Liang-Ping Xia 
【机 构】
：
VIP Department,Sun Yat-sen University Cancer Center,Guangzhou,Guangdong,People's Republic of China;
【出 处】
：
第五届广州国际肿瘤学会议暨第一届中国抗癌协会肿瘤靶向治疗专业委员会年会
【发表日期】
：
2016年11期
【关键词】
：
Periyte coverage bevacizumab predictive marker overall survival metastatic color 
下载到本地 , 更方便阅读
下载此文 赞助VIP
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
　　Background: Tumor vessels supported by pericytes were considered to be responsible for the failure of some anti-angiogenic agents.It remains undefined when it comes to bevacizumab.We tried to analysis the relationship between the pericyte coverage(PC)and bevacizumab efficacy in metastatic colorectal cancer(mCRC).
其他文献
Relative Abundance of EGFR Mutations Predict Tumor Metastasis and EGFR-TKIs Prognosis in Patients wi
Aims: Non-small cell Cancer(NSCLC)is the leading cause of cancer-related deaths in the worldwide.The most lethality in NSCLC is due to uncontrolled tumor metastasis(e.g.,brain,bone and hepar metastasi
会议
EGFR mututionLocationAbundanceMetastasisPrognosisProspective study
Mecp2-mediated Epigenetic Silencing of miR-137 Contributes to Colorectal Adenoma-Carcinoma Sequence
The molecular mechanisms underlying colorectal cancer(CRC)development remain elusive.In this study,we examined the miRNA and mRNA expressions in the adenoma-carcinoma sequence(ACS),a critical neoplast
会议
colorectal canceradenoma carcinoma sequencemiR-137c-MetMecp2
Prognostic Value of PD-L1,PD-L2,PD-1,and CD8(+)T cell Expression Density in Primary Gastric Cancer T
Background: Clinical trials have revealed a important but not consistent association between programmed death ligand-1(PD-L1)expression and response to checkpoint blockade therapy.How to define a thre
会议
gastric cancerPD-L1PD-L2PD-1CD8(+) T cellsheterogeneity expression
Serum level of IL-6 and AFP associates with survival of HCC patients
Background and Aims: An increasing number of research has revealed that the immune microenvironment of hepatocellular carcinoma(HCC)is associated with tumor development.Lots of inflammatory factors ar
会议
AFPHCCIL-6inflammatory factorprognosis
Efficacy of radiotherapy for patients with unresectable or recurrent locally advanced gastric carcin
Background: Gastric cancer(GC)is the fourth most common malignant disease worldwide and the second most common cause of death from cancer.Most patients are initially diagnosed with unresectable,locall
会议
gastric cancerradiotherapysurvival
A new staging system for survival prognosis in patients with gastric neuroendocrine neoplasms:a mult
Background:The ability of the 2010 World Health Organization(WHO)grading system,and American Joint Committee on Cancer(AJCC)staging system to stratify patients with gastric neuroendocrine tumors(g-NET
会议
gradinggastric euroendocrine tumorsstagingGNMTNM
Mutant Kras-and p16-Regulated NOX4 Activation Overcomes Metabolic Checkpoints in Development of Panc
Background: Kras activation and p16 inactivation are required for development of pancreatic ductal adenocarcinoma(PDAC).However,the biochemical mechanisms underlying these double alterations remain un
会议
Krasp16GlycolysisNOX4NAD+/NADH
Myeloid Deprived Suppressor Cell Mediated the Prognostic Value of Neutrophil for Advanced Hepatocell
Myeloid Deprived Suppressor Cell(MDSC)has been raised to be a novel target for multiple cancers.However,target agents on MDSC has not displayed promising efficacy.One of the critical reasons shall be
会议
NeutrophilcountsHepatocellular carcinomaPatient selectionPrognosisMyeloid de
人结肠癌裸鼠移植瘤模型的制备及其生物学特性研究
目的 构建人结肠癌裸鼠皮下移植瘤模型、经脾注射肝转移模型及盲肠原位移植瘤模型.方法 将人结肠癌细胞(HCT-116)接种于裸鼠皮下及脾被膜下,分别构建皮下移植瘤模型和经脾注射肝转移模型；以裸鼠皮下肿瘤为瘤源,将其剪切后移植于另一组裸鼠盲肠浆膜下,构建原位移植瘤模型.[结果]皮下移植瘤模型均有成瘤,但未见到局部侵袭、淋巴转移及血行转移等现象；经脾肝转移模型建模6 周后脾脏成瘤率为100％(6/6),
会议
结直肠癌移植瘤动物模型
The association of metabolic characteristics in colon cancer cells and sensitivity to standard chemo
Oxaliplatin(OX)and 5-fluorouracil(5-FU)are two chemotherapeutic agents for colon cancer.However,the chemoresistance to such conventional therapeutic agents still remains a major challenge in cancer tr
会议